Clinicians often have a knowledge gap when it comes to navigating the CBD industry and providing evidence-based counseling to their communities.
This webinar will cover the therapeutic potential and current scientific evidence regarding hemp-derived CBD products. It will focus on the opportunity of CBD as a novel therapeutic option for pain management and decrease opioid use. You will learn about the endocannabinoid system, as well as the mechanisms of action, and differences between CBD and other cannabinoids.
Attendees will review the CBD market, legal aspects, and guidance for assessing quality assurance. Dosing guidelines for CBD & cannabinoid, along with drug interactions, side-effects, and appropriate use will be presented with supporting statistics from recent studies.
• What the term CBD means
• The physiology of the mammalian endocannabinoid system (ECS), particularly as a messaging system for biological activity
• The primary therapeutic benefits within the ECS through the use of phytocannabinoids
• The pharmacology and potential efficacy of the non-psychoactive phytocannabinoid cannabidiol (CBD) as a therapeutic treatment, including safety profile, drug interactions, dose recommendations
• To recognize, select and assemble the up-to-date scientific resources on CBD therapy to provide appropriate patient counseling and care through this evolving industry.
Important note: CBD products are not available on the Fullscript platform. Products mentioned in this presentation can be wholesale purchased through Natural Partners.
Are you a healthcare practitioner? Consider signing up with Fullscript:
Questions? Reach us at
Make sure to follow us on: